As per the research report, the size of the Asia Pacific Theranostics Market is estimated to grow at a healthy CAGR during the forecast period. Theranostics is a combination of drug therapy and diagnostics.
The growing occurrence rate of cancer and the large patient pool is a significant factor fueling the market. Funds and investments from government and other healthcare organizations towards the research and development in drug synthesis to deal with new and killing diseases are propelling the theranostics market growth during the period. People who are more prone to suffer from diseases like various kinds of cancer and other chronic ailments is expected to drive the theranostics market in this region. FDA approvals for new drug discovery and diagnostics procedures and the devices used for diagnosing are expected to spur the market growth over the period. Mergers, partnerships, and collaborations by the key players for manufacturing in developing new companion diagnostics are to surge the theranostics market over the forecasting framework.
Cost related to the therapy and diagnostics is so expensive, which is the primary factor restraining the market growth over the analysis period. Moreover, strict regulatory frameworks for the product approvals and also drug discovery are limiting the market growth in this region. Also, the lack of awareness among the patients regarding the diagnosis of the diseases and the therapy related to the disorders may impede the market negatively.
This research report on the APAC Theranostics Market has been segmented and sub-segmented into the following categories:
By Disease Type:
By Technology:
By End-User:
By Country:
China holds a significant share in the market due to the presence of market leaders as well as developed healthcare and pharmaceutical infrastructure. India is the fastest-growing region due to increasing expenditure on health care, product innovation, and rising disposable income. Based on Disease Type, Neurological disorders are the holding the significant share in the market due to prevalence of diseases like Parkinson’s Disease, Alzheimer’s Disease and other prevalent diseases, meanwhile, cancer diseases and cardiovascular disorders are expected to grow the fastest due to increasing risk rate and prevalence of these diseases and increasing research expenditure by pharmaceutical companies.
Top companies leading in the APAC Theranostics Market profiled in the report are Abbott Laboratories, AmeriPath, Dickinson and Company, BIOTEC Laboratories, Dade Behring, Dianon Systems, Dynacare Laboratories, Enterix, Focus Diagnostics, Pfizer and Beckman Coulter.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Disease Type
5.1.1 Introduction
5.1.2 Neurological Disorders
5.1.3 Cardiovascular Diseases
5.1.4 Cancers
5.1.5 Others
5.1.6 Y-o-Y Growth Analysis, By Disease Type
5.1.7 Market Attractiveness Analysis, By Disease Type
5.1.8 Market Share Analysis, By Disease Type
5.2 By Technology
5.2.1 Introduction
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Immunohistochemistry
5.2.4 In Situ Hybridization
5.2.5 Sequencing
5.2.6 Others
5.2.7 Y-o-Y Growth Analysis, By Technology
5.2.8 Market Attractiveness Analysis, By Technology
5.2.9 Market Share Analysis, By Technology
5.3 By End User
5.3.1 Hospitals
5.3.2 Diagnostics Laboratories
5.3.3 Others
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Disease Type
6.1.3.3 By Technology
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Disease Type
6.1.4.3 By Technology
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Disease Type
6.1.5.3 By Technology
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Abbott Laboratories
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 AmeriPath
8.3 Dickinson and Company
8.4 BIOTEC Laboratories
8.5 Dade Behring
8.6 Dianon Systems
8.7 Dynacare Laboratories
8.8 Enterix
8.9 Focus Diagnostics
8.10 Pfizer
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
